Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Eduardo Osinaga; Teresa Freire; Luis Ubillos

doi:10.1002/ijc.30246

Journal articles

Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Eduardo Osinaga ^{1, 2} Teresa Freire ^{1, 2} Luis Ubillos ²

1 Institut Pasteur de Montevideo

2 Departamento de inmunobiologia

Domain :

Life Sciences [q-bio]

Complete list of metadatas

https://hal-riip.archives-ouvertes.fr/pasteur-01499032
Contributor : Mariella Botta <>
Submitted on : Thursday, March 30, 2017 - 8:20:24 PM
Last modification on : Friday, February 22, 2019 - 11:16:45 AM

Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Links full text

Identifiers

Collections

Citation

Export

Metrics

52

Contact

Informations

Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

52

Contact

Informations